Seoul, South Korea

Kwang Won Jeong

This inventor holds 13 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignees: Choongwae Pharma Corporation, Autophagysciences Inc.. Active years: 2004-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kwang Won Jeong. Retrieved from https://idiyas.com/inventor/kwang-won-jeong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 

% Patents Active = 46.2


 

Average Co-Inventor Count = 7.0

ph-index = 5

Forward Citations = 113(Granted Patents)


Location History:

  • Seoul, KR (2004 - 2014)
  • Incheon, KR (2020)

Company Filing History:


Years Active: 2004-2020

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Kwang Won Jeong: Innovator in Pharmaceutical Sciences

Introduction

Kwang Won Jeong is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceutical sciences, holding a total of 13 patents. His work focuses on innovative compounds that have the potential to address various health issues.

Latest Patents

Among his latest patents is a catechol derivative and pharmaceutical composition comprising the same. This invention relates to a compound represented by Chemical Formula 1 or a pharmaceutically acceptable salt thereof. The compound can be effectively used for the prevention or treatment of autophagy-related diseases. Another notable patent is for reverse-turn mimetics and methods relating thereto. This patent discloses conformationally constrained compounds that mimic the secondary structure of reverse-turn regions of biologically active peptides and proteins. These reverse-turn mimetic structures have utility across a wide range of fields, including diagnostic and therapeutic applications. The invention also addresses the use of such compounds for inhibiting or treating disorders modulated by the Wnt-signaling pathway, including various cancers and other diseases.

Career Highlights

Kwang Won Jeong has worked with notable companies such as Choongwae Pharma Corporation and Autophagysciences Inc. His career reflects a commitment to advancing pharmaceutical research and development.

Collaborations

Throughout his career, Kwang Won Jeong has collaborated with esteemed colleagues,

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…